Linus Angenendt

1.1k total citations
29 papers, 404 citations indexed

About

Linus Angenendt is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Linus Angenendt has authored 29 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 13 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Linus Angenendt's work include Acute Myeloid Leukemia Research (17 papers), CAR-T cell therapy research (5 papers) and Peptidase Inhibition and Analysis (5 papers). Linus Angenendt is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), CAR-T cell therapy research (5 papers) and Peptidase Inhibition and Analysis (5 papers). Linus Angenendt collaborates with scholars based in Germany, Switzerland and United States. Linus Angenendt's co-authors include Christoph Schliemann, Wolfgang E. Berdel, Carsten Müller‐Tidow, Tim Sauer, Sandhya Sharma, Michael Schmitt, Stephen Gottschalk, Qian Chen, Kathan Parikh and Bilal Omer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Linus Angenendt

27 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linus Angenendt Germany	11	204	173	104	103	58	29	404
Kathryn J. Newhall United States	14	288 1.4×	225 1.3×	131 1.3×	153 1.5×	66 1.1×	25	535
Paola Dama United Kingdom	9	180 0.9×	223 1.3×	61 0.6×	118 1.1×	38 0.7×	18	448
Ken Nguyen United States	7	181 0.9×	263 1.5×	60 0.6×	127 1.2×	31 0.5×	12	526
Huimin Meng China	14	357 1.8×	209 1.2×	88 0.8×	265 2.6×	63 1.1×	34	582
Christine Rivat United Kingdom	8	211 1.0×	231 1.3×	113 1.1×	106 1.0×	84 1.4×	14	450
Geoffrey Shouse United States	14	328 1.6×	387 2.2×	60 0.6×	73 0.7×	43 0.7×	71	664
Lida Pacaud United States	12	520 2.5×	245 1.4×	113 1.1×	84 0.8×	58 1.0×	56	621
Sonya H.L. Lam Canada	10	185 0.9×	292 1.7×	78 0.8×	75 0.7×	23 0.4×	15	466
Rizi Ai United States	12	79 0.4×	332 1.9×	85 0.8×	114 1.1×	43 0.7×	17	587

Countries citing papers authored by Linus Angenendt

Since Specialization

Citations

This map shows the geographic impact of Linus Angenendt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linus Angenendt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linus Angenendt more than expected).

Fields of papers citing papers by Linus Angenendt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linus Angenendt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linus Angenendt. The network helps show where Linus Angenendt may publish in the future.

Co-authorship network of co-authors of Linus Angenendt

This figure shows the co-authorship network connecting the top 25 collaborators of Linus Angenendt. A scholar is included among the top collaborators of Linus Angenendt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linus Angenendt. Linus Angenendt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Walter, Carolin, Vijay Alla, Linus Angenendt, et al.. (2024). Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia. Blood. 143(22). 2284–2299. 4 indexed citations

Evers, Georg, Christian Reicherts, Linus Angenendt, et al.. (2023). Prevalence and clinical impact of CD56 and T‐cell marker expression in acute myeloid leukaemia: A single‐centre retrospective analysis. SHILAP Revista de lepidopterología. 5(1). 93–104.

Angenendt, Linus, Torsten Keßler, Rolf M. Mesters, et al.. (2023). Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysis. Annals of Hematology. 102(4). 755–760. 4 indexed citations

Thiele, Sebastian, Jörg Gromoll, Stefan Schlatt, et al.. (2023). Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears. Blood Advances. 8(1). 70–79. 10 indexed citations

Schülke, Christoph, Christian Reicherts, Julia Marx, et al.. (2023). Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML). Annals of Hematology. 102(9). 2543–2553. 4 indexed citations

Koch, Raphael, Joachim Gerß, Marcus Hentrich, et al.. (2022). A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy. Annals of Hematology. 102(1). 63–72. 1 indexed citations

Angenendt, Linus, Jan‐Henrik Mikesch, & Christoph Schliemann. (2022). Emerging antibody-based therapies for the treatment of acute myeloid leukemia. Cancer Treatment Reviews. 108. 102409–102409. 5 indexed citations

Sauer, Tim, Kathan Parikh, Sandhya Sharma, et al.. (2021). CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity. Blood. 138(4). 318–330. 142 indexed citations

Angenendt, Linus, Marius Wöste, Jan‐Henrik Mikesch, et al.. (2021). Calcitonin receptor-like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML. Blood Advances. 5(21). 4413–4421. 14 indexed citations

10.

Angenendt, Linus, Jan‐Henrik Mikesch, Bernhard Schlüter, et al.. (2020). Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Annals of Hematology. 100(7). 1871–1878. 4 indexed citations

11.

Wethmar, Klaus, Eva Eßeling, Linus Angenendt, et al.. (2020). Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia. Bone Marrow Transplantation. 55(7). 1410–1420. 7 indexed citations

12.

Angenendt, Linus, Jan‐Henrik Mikesch, Dennis Görlich, et al.. (2018). Stromal collagen type VI associates with features of malignancy and predicts poor prognosis in salivary gland cancer. Cellular Oncology. 41(5). 517–525. 8 indexed citations

13.

Mikesch, Jan‐Henrik, Wolfgang Hartmann, Linus Angenendt, et al.. (2018). AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report. Cellular Oncology. 41(4). 455–462. 7 indexed citations

14.

Mikesch, Jan‐Henrik, Wolfgang Hartmann, L. H. Schmidt, et al.. (2018). Reptin drives tumour progression and resistance to chemotherapy in nonsmall cell lung cancer. European Respiratory Journal. 52(1). 1701637–1701637. 8 indexed citations

15.

Keßler, Torsten, Caroline Brand, Michael Grau, et al.. (2018). Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma. Translational Oncology. 11(6). 1271–1282. 19 indexed citations

16.

Alla, Vijay, Linus Angenendt, Christoph Schliemann, et al.. (2017). RNA-Guided CRISPR-Cas9 System-Mediated Engineering of Acute Myeloid Leukemia Mutations. Molecular Therapy — Nucleic Acids. 6. 243–248. 15 indexed citations

17.

Schliemann, Christoph, Joachim Gerß, Jan‐Henrik Mikesch, et al.. (2016). A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia. PLoS ONE. 11(10). e0164499–e0164499. 13 indexed citations

18.

Brand, Caroline, Christoph Schliemann, Janine Ring, et al.. (2016). NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor. Oncotarget. 7(6). 6774–6789. 20 indexed citations

19.

Wenge, Daniela V., Linus Angenendt, Christoph Schliemann, et al.. (2015). MN1–Fli1 oncofusion transforms murine hematopoietic progenitor cells into acute megakaryoblastic leukemia cells. Oncogenesis. 4(12). e179–e179. 10 indexed citations

20.

Schwöppe, Christian, Linus Angenendt, Torsten Keßler, et al.. (2015). Potentiating the activity of rituximab against mantle cell lymphoma in mice by targeting interleukin-2 to the neovasculature. Leukemia Research. 39(7). 739–748. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact